Next report date
Report period
Q1 2024
EPS estimate
−0.20USD
Revenue estimate
—
−1.53USD
−45.70 MUSD
37.99 M
About Elevation Oncology, Inc.
Sector
Industry
CEO
Joseph J. Ferra
Website
Headquarters
Boston
Employees (FY)
29
Founded
2019
FIGI
BBG00W7CX151
Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in Boston, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where ELEV is featured.
Frequently Asked Questions
The current price of ELEV is 3.63 USD — it has decreased by 0.41% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Elevation Oncology, Inc. stocks are traded under the ticker ELEV.
Elevation Oncology, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
ELEV stock is 5.80% volatile and has beta coefficient of 1.91. Check out the list of the most volatile stocks — is Elevation Oncology, Inc. there?
ELEV earnings for the last quarter are −0.25 USD per share, whereas the estimation was −0.31 USD resulting in a 19.35% surprise. The estimated earnings for the next quarter are −0.23 USD per share. See more details about Elevation Oncology, Inc. earnings.
Yes, you can track Elevation Oncology, Inc. financials in yearly and quarterly reports right on TradingView.
ELEV stock has fallen by 9.25% compared to the previous week, the month change is a 29.38% fall, over the last year Elevation Oncology, Inc. has showed a 21.40% increase.
ELEV net income for the last quarter is −7.90 M USD, while the quarter before that showed −10.64 M USD of net income which accounts for 25.73% change. Track more Elevation Oncology, Inc. financial stats to get the full picture.
Today Elevation Oncology, Inc. has the market capitalization of 177.33 M, it has decreased by 7.74% over the last week.
No, ELEV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ELEV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Elevation Oncology, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 29.00 employees. See our rating of the largest employees — is Elevation Oncology, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Elevation Oncology, Inc. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Elevation Oncology, Inc. stock shows the buy signal. See more of Elevation Oncology, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Elevation Oncology, Inc. future price: according to them, ELEV price has a max estimate of 10.00 USD and a min estimate of 6.00 USD. Read a more detailed Elevation Oncology, Inc. forecast: see what analysts think of Elevation Oncology, Inc. and suggest that you do with its stocks.